ASLN(Delisted)
ASLAN Pharmaceuticals·NASDAQ
--
--(--)
ASLN Filings
Filing Date
Form Description
Form Type
2024-11-14
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Ownership
2024-11-14 · Ownership
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-11-14
Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Ownership
2024-11-14 · Ownership
Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024-09-06
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Key Events
2024-09-06 · Key Events
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024-08-08
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-08-08 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-07-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2024-07-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2024-07-15
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2024-07-15 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2024-06-24
Form EFFECT - Notice of Effectiveness
2024-06-24 ·
Form EFFECT - Notice of Effectiveness
2024-06-18
Form CORRESP - Correspondence
SEC Inquiries
2024-06-18 · SEC Inquiries
Form CORRESP - Correspondence
2024-06-14
Form UPLOAD - SEC-generated letter
SEC Inquiries
2024-06-14 · SEC Inquiries
Form UPLOAD - SEC-generated letter
2024-06-14
Form F-6 POS - Post-effective amendments for immediately effective filing
2024-06-14 ·
Form F-6 POS - Post-effective amendments for immediately effective filing
